Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Opinions The Panic-Proof Portfolio (Stockchase Research)
Harvest Big Pharma Split Corp.PRM.TOTOP PICKFeb 03, 2026
$14.60
Stock price when the opinion was issued
$13.70
As of Jun 12, 2026. Market Open.
Pharma & Healthcare
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
;fill-opacity:1;'/%3e%3cpath%20d='M31%2018.6001V30H8V18.6001L14.1334%2022.4334L19.4999%2014L24.8669%2022.4334L31%2018.6001Z'%20fill='%23EE5432'%20style='fill:%23EE5432;fill:color(display-p3%200.9340%200.3310%200.1956);fill-opacity:1;'/%3e%3c/svg%3e){kind=small}
Premium contentTOP PICK
Stockchase Research Editor: Michael O'Reilly
PRM hold a portfolio of 10 of the world's largest pharmaceutical and biotechnology companies. The fund managers use a balance of the underlying shares with dividends and options to create an enhanced yield. We like that recent earnings show healthy and growing cash reserves. The shares held their value during the severe market downturns in 2018 and 2022 -- actually increasing 11% in each -- providing good market volatility protection. We recommend setting a stop-loss at $10.00, looking to achieve $15.00 -- upside potential of 18%. Yield 7.2%
Pharma & Healthcare
We reiterate PRM, a portfolio of the 10 world's largest pharma and biotech companies, as a TOP PICK. The fund manages a balance of underlying shares with dividends and options to create an enhanced yield for investors, which presently yields over 8%. We recommend trailing up the stop (from $10) to $13, looking to achieve $18 -- upside over 18%. Yield 8.2%
(Analysts’ price target is $32.78)